Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Omipalisib | 3.1623 | uM | 5 | 156.25 | 28.48 | 67.00 | 69.50 | 0.9640 | 0.9439 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 43.00 | 69.50 | 0.6187 | 0.3773 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 78.00 | 69.50 | 1.1223 | 1.1876 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 181.00 | 204.00 | 0.8873 | 0.6129 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 155.00 | 204.00 | 0.7598 | 0.2204 | |
| SK-BR-3 | Methotrexate | 0.031623 | uM | 5 | 312.50 | 138.75 | 154.00 | 204.00 | 0.7549 | 0.2063 |
| SK-BR-3 | Omipalisib | 1 | uM | 5 | 312.50 | 138.75 | 126.00 | 204.00 | 0.6177 | -0.1592 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 5 | 312.50 | 138.75 | 213.00 | 204.00 | 1.0441 | 1.1615 |
| SK-BR-3 | Taxol | 0.031623 | uM | 5 | 312.50 | 138.75 | 150.00 | 204.00 | 0.7353 | 0.1505 |
| SK-BR-3 | Palbociclib | 10 | uM | 5 | 312.50 | 138.75 | 154.00 | 204.00 | 0.7549 | 0.2063 |
| SK-BR-3 | Palbociclib | 0.0033113 | uM | 5 | 312.50 | 138.75 | 245.00 | 204.00 | 1.2010 | 1.7801 |
| SK-BR-3 | Taxol | 0.01 | uM | 5 | 312.50 | 138.75 | 142.00 | 204.00 | 0.6961 | 0.0425 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 5 | 312.50 | 138.75 | 227.00 | 204.00 | 1.1127 | 1.4236 |
| SK-BR-3 | Methotrexate | 0.01 | uM | 5 | 312.50 | 138.75 | 254.00 | 204.00 | 1.2451 | 1.9664 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 5 | 312.50 | 138.75 | 297.00 | 204.00 | 1.4559 | 2.9299 |
| SK-BR-3 | Taxol | 0.00033113 | uM | 5 | 312.50 | 138.75 | 311.00 | 204.00 | 1.5245 | 3.2693 |
| SK-BR-3 | Palbociclib | 0.1 | uM | 5 | 312.50 | 138.75 | 218.00 | 204.00 | 1.0686 | 1.2536 |
| SK-BR-3 | Omipalisib | 10 | uM | 5 | 312.50 | 138.75 | 95.00 | 204.00 | 0.4657 | -0.4940 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 211.00 | 204.00 | 1.0343 | 1.1251 | |
| SK-BR-3 | Palbociclib | 1 | uM | 5 | 312.50 | 138.75 | 231.00 | 204.00 | 1.1324 | 1.5010 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 5 | 312.50 | 138.75 | 192.00 | 204.00 | 0.9412 | 0.7934 |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 5 | 312.50 | 138.75 | 163.00 | 204.00 | 0.7990 | 0.3360 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 5 | 312.50 | 138.75 | 229.00 | 204.00 | 1.1225 | 1.4621 |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 5 | 312.50 | 138.75 | 157.00 | 204.00 | 0.7696 | 0.2489 |
| SK-BR-3 | Taxol | 0.1 | uM | 5 | 312.50 | 138.75 | 165.00 | 204.00 | 0.8088 | 0.3656 |